# Ceftriaxone to PRevent pneumOnia and inflammatTion aftEr Cardiac arresT (PROTECT)

> **NCT04999592** · PHASE2 · TERMINATED · sponsor: **David J. Gagnon** · enrollment: 53 (actual)

## Conditions studied

- Out-Of-Hospital Cardiac Arrest
- Pneumonia

## Interventions

- **DRUG:** Standard of care without prophylaxis
- **DRUG:** Antibiotic prophylaxis

## Key facts

- **NCT ID:** NCT04999592
- **Lead sponsor:** David J. Gagnon
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-08-20
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-11-01
- **Target enrollment:** 53 (ACTUAL)
- **Why stopped:** Lapse in funding
- **Last updated:** 2025-04-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04999592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04999592, "Ceftriaxone to PRevent pneumOnia and inflammatTion aftEr Cardiac arresT (PROTECT)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04999592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*